There are 2949 resources available
FGFR inhibitors
Presenter: Yohann Loriot
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Antibody Drug Conjugate (ADC)
Presenter: Victor Moreno Garcia
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Epigenetic drugs: EZH2, BET and LDSD1
Presenter: Sophie Postel-Vinay
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Future strategies of using radiotherapy as an immune-stimulating agent
Presenter: Fernanda Herrera
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Natasha Leighl
Session: Maximising the benefit of immuno-oncology
Resources:
Webcast
Q&A and live discussion
Presenter: Irene Braña
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Webcast
Cancer burden and prevention initiatives around the world: What are the preventable diseases?
Presenter: Freddie Bray
Session: How can we reduce cancer numbers? (in collaboration with ASCO)
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Lori Pierce
Session: How can we reduce cancer numbers? (in collaboration with ASCO)
Resources:
Webcast
Q&A and live discussion
Presenter: Jordi Rodon
Session: New drugs in development: What will be approved in 2025?
Resources:
Webcast
Q&A and live discussion
Presenter: Dan Landau
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Webcast